APA (7th ed.) Citation

Liu, B., Yin, L., Chen, Y., Hou, X., Li, Y., Liu, X., & Liu, R. Efficacy and safety of TACE-HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for the patients with BCLC-defined stage B-C HCC. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Liu, Bowen, Linan Yin, Yuxin Chen, Xunbo Hou, Yingchen Li, Xuesong Liu, and Ruibao Liu. Efficacy and Safety of TACE-HAIC Combined with Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for the Patients with BCLC-defined Stage B-C HCC. Frontiers Media S.A.

MLA (9th ed.) Citation

Liu, Bowen, et al. Efficacy and Safety of TACE-HAIC Combined with Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for the Patients with BCLC-defined Stage B-C HCC. Frontiers Media S.A.